Terms: = Lung cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Diagnosis
184 results:
1. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Recurrent Breast cancer That Was brca1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor].
Aoyagi T; Namura M; Sakata H; Tamanuki T; Iwai M; Iwata K; Takahashi H; Matsuzaki H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1462-1464. PubMed ID: 38303308
[TBL] [Abstract] [Full Text] [Related]
3. Intraocular medulloepithelioma: an unusual and challenging entity in paediatric population.
Imam U; Hameed M; Anis I; Bhutto I; Ahmed SH; Rizvi A; Ahmad Z
J Pak Med Assoc; 2023 Dec; 73(12):2469-2472. PubMed ID: 38083935
[TBL] [Abstract] [Full Text] [Related]
4. Rate of Pathogenic Germline Variants in Patients With lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
Stålhammar G
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
[TBL] [Abstract] [Full Text] [Related]
6. Enhancing Symptom Screening and Patient Education Among Patients with Metastatic lung cancer: a Qualitative Analysis.
Safavi AH; Bryson E; Delibasic V; Tjong MC; Hallet J; Mahar A; Davis LE; Wright FC; Parmar A; Coburn NG; Louie AV
J Cancer Educ; 2024 Feb; 39(1):86-95. PubMed ID: 37962792
[TBL] [Abstract] [Full Text] [Related]
7. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
Aydogdu G; Özekinci S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report.
Del Giglio A; da Costa Aguiar Alves B; Murad AM; Fonseca FLA
J Med Case Rep; 2023 Sep; 17(1):407. PubMed ID: 37743480
[TBL] [Abstract] [Full Text] [Related]
9. Clinical utility of [
Zhang L; E H; Huang J; Wu J; Li Q; Hou L; Li C; Dai C; Deng J; Yang M; Ma M; Ren Y; Luo Q; Zhao D; Chen C
Eur Radiol; 2023 Dec; 33(12):8564-8572. PubMed ID: 37464112
[TBL] [Abstract] [Full Text] [Related]
10. New Markers for Management of Mesothelioma.
Nash A; Firth Née Phan T; Creaney J
Semin Respir Crit Care Med; 2023 Aug; 44(4):491-501. PubMed ID: 37253383
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
12. Mutations and expressions of breast cancer 1/2 in lung cancer.
Yan B; Xie B; Huang M; Guo J; Sun J; Chen J; Tao Y; Xiao D
Thorac Cancer; 2023 Jun; 14(18):1753-1763. PubMed ID: 37160413
[TBL] [Abstract] [Full Text] [Related]
13. Acquired Angioedema in Selected Neoplastic Diseases.
Zając M; Bożek A; Kozłowska R; Grzanka A
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109602
[No Abstract] [Full Text] [Related]
14. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
[TBL] [Abstract] [Full Text] [Related]
15. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
16. The cytologic diagnosis of mesothelioma: are we there yet?
Michael CW
J Am Soc Cytopathol; 2023; 12(2):89-104. PubMed ID: 36702736
[TBL] [Abstract] [Full Text] [Related]
17. Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia.
Widiasari NPA; Rai IBN; Dwi Kusumawardani IAJ; Sajinadiyasa IGK; Candrawati NW; Arisanti NLPE
Rom J Intern Med; 2023 Mar; 61(1):63-71. PubMed ID: 36453446
[No Abstract] [Full Text] [Related]
18. Malignant pleural mesothelioma in situ.
Ando K; Morohoshi T; Tsuura Y; Masuda M
Interact Cardiovasc Thorac Surg; 2022 Oct; 35(5):. PubMed ID: 36205712
[TBL] [Abstract] [Full Text] [Related]
19. Constitutional brca1 Methylation and Risk of Incident Triple-Negative Breast cancer and High-grade Serous Ovarian cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma.
Lynggård LA; Panou V; Szejniuk W; Røe OD; Meristoudis C
J Am Soc Cytopathol; 2022; 11(6):385-393. PubMed ID: 35945149
[TBL] [Abstract] [Full Text] [Related]
[Next]
